Integra LifeSciences Holdings Corporation provided earnings guidance for the first quarter and for the full year 2024. For the quarter, the company expects revenues in the range of $360 million to $365 million, representing reported growth of approximately -5.5% to -4.1% and organic growth of approximately -5.1% to -3.7%.

For the period, the company expects revenues to be in a range of $1,603 million to $1,618 million, representing reported growth of approximately 4.0% to 5.0% and organic growth in the range of 4.0% to 5.0%.